Announcement
23 May 2023 1min read

UICC signs a declaration calling for urgent action to make cervical cancer elimination a reality

UICC has supported the call to eliminate cervical cancer since 2018 and is honoured to add its name as signatory to a new declaration, which has already garnered more than 1,200 signatories in 113 countries – and counting. 

The Global Declaration to Eliminate Cervical Cancer, signed by leading public health experts, scientists, health care providers and advocates from around the world, supports WHO’s Global Strategy to accelerate cervical cancer elimination .

In particular, it aims to build political and financial commitments to ensure access to HPV vaccines everywhere, and expand access to cervical cancer screening, diagnostics and treatment services

Five years ago, at the 2018 World Health Assembly, WHO’s Dr. Tedros Adhanom Ghebreyesus called for global action to eliminate cervical cancer, which led to the adoption of the Global Strategy in 2020. The pandemic, challenges with HPV vaccine supply and inequitable access to HPV vaccines, as well as screening and treatment programmes, have limited progress towards the 2030 targets outlined in the Global Strategy to have 90% of girls fully vaccinated with the HPV vaccine by age 15, 70% of women are screened with a high-performance test by 35 and 45 years of age, and 90% of women identified with cervical disease receive treatment.

Multiple manufacturers are now producing HPV vaccines, one-dose regimens are showing promise, and countries such as Australia and Rwanda have made excellent progress toward eliminating cervical cancer.

This latest Global Declaration to Eliminate Cervical Cancer is co-led by 12 leading scientists, health care providers, and advocates for immunisation, cancer eradication and women’s health around the world.

UICC has supported the call to eliminate cervical cancer since 2018 and is honoured to add its name as signatory to the declaration. 

Read the Global Declaration

Last update

Thursday 01 June 2023

Share this page

Related content

Diverse group of people standing in rows on a staircase, the TNM Core Committee

Dr Matejka Rebolj and Jane Rigney, from the Centre for Cancer Screening, Prevention and Early Diagnosis, Queen Mary University of London, lend their reflections on the meeting in Brussels, how to reverse the decline in cervical cancer screening, and the importance of hearing from people with lived experience.

Close up of a patient receiving an injection

Mathematical models shaped responses to COVID-19 and guide cancer prevention programmes such cervical cancer screening and HPV vaccination, highlighting their critical role in health strategy development.